相关实验视频

Updated: Jun 28, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

针对固体瘤的CAR-T细胞疗法的当前挑战和治疗进展

Tong Chen¹, Mingzhao Wang¹, Yanchao Chen¹

¹Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.

Cancer cell international

|April 15, 2024

概括

化学抗原受体 (CAR) T细胞疗法对固体瘤具有前景,但面临瘤特异性和毒性等挑战. 在CAR-T设计,交付和组合疗法的创新是改善患者治疗结果的关键.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) T细胞疗法是血液恶性瘤的突破.
在固体瘤中,CAR-T疗法面临着显著的局限性,包括缺乏特定标,免疫抑制微环境和T细胞功能障碍.

研究的目的:

审查CAR-T细胞治疗固体瘤的历史和最近的进展.
探索提高CAR-T细胞在固体瘤治疗中的疗效的策略.

主要方法:

关于CAR-T细胞治疗史和进展的文献综述.
对优化CAR-T细胞设计,输送和结合治疗固体瘤的最新研究进行分析.

主要成果:

优化CAR-T细胞设计,采用逻辑门的CAR-T细胞,并改进交付方法可以提高疗效.
组合疗法提供了一个有希望的策略,以提高CAR-T细胞的有效性.
许多临床试验正在进行中,用于固体瘤的CAR-T细胞治疗.

结论:

对于固体瘤治疗来说,CAR-T细胞疗法具有显著的潜力和挑战.
在CAR-T细胞治疗中持续创新对于克服现有的障碍和改善患者反应至关重要.

关键词:

抗原是一种抗原.在CAR T细胞疗法中.临床试验临床试验是指临床试验的临床试验.结合疗法结合疗法结合疗法异质性异质性异质性固体瘤是一个固体瘤.T细胞耗尽的情况有毒性有毒性瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...